91 related articles for article (PubMed ID: 21792021)
1. An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension.
Schillaci G; De Vuono S; Pucci G
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):609-12. PubMed ID: 21792021
[No Abstract] [Full Text] [Related]
2. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
[TBL] [Abstract][Full Text] [Related]
3. The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.
Durakoğlugil ME; Ayaz T; Kocaman SA; Kırbaş A; Durakoğlugil T; Erdoğan T; Çetin M; Şahin OZ; Çiçek Y
Anatol J Cardiol; 2015 Jul; 15(7):577-85. PubMed ID: 25538000
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Adamkova V
Vnitr Lek; 2013 Sep; 59(9):759. PubMed ID: 24187716
[No Abstract] [Full Text] [Related]
6. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling.
Meng L; Wang J; Ding WH; Han P; Yang Y; Qi LT; Zhang BW
Postgrad Med J; 2013 Apr; 89(1050):193-6. PubMed ID: 23223776
[TBL] [Abstract][Full Text] [Related]
7. Catestatin-A Novel Predictor of Left Ventricular Remodeling After Acute Myocardial Infarction.
Zhu D; Xie H; Wang X; Liang Y; Yu H; Gao W
Sci Rep; 2017 Apr; 7():44168. PubMed ID: 28397784
[TBL] [Abstract][Full Text] [Related]
8. Potential applications of catestatin in cardiovascular diseases.
Zhao Y; Zhu D
Biomark Med; 2016 Aug; 10(8):877-88. PubMed ID: 27415768
[TBL] [Abstract][Full Text] [Related]
9. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure.
Mahapatra NR
Cardiovasc Res; 2008 Dec; 80(3):330-8. PubMed ID: 18541522
[TBL] [Abstract][Full Text] [Related]
10. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
Ann N Y Acad Sci; 2002 Oct; 971():533-5. PubMed ID: 12438176
[No Abstract] [Full Text] [Related]
11. Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.
Wang X; Xu S; Liang Y; Zhu D; Mi L; Wang G; Gao W
Biomarkers; 2011 Jun; 16(4):372-7. PubMed ID: 21545240
[TBL] [Abstract][Full Text] [Related]
12. The associations between anxiety/depression and plasma chromogranin A among healthy workers: Results from EHOP study.
Li Y; Song Y; Dang W; Guo L; Xu W
J Occup Health; 2020 Jan; 62(1):e12113. PubMed ID: 32515855
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin).
Ying W; Tang K; Avolio E; Schilling JM; Pasqua T; Liu MA; Cheng H; Gao H; Zhang J; Mahata S; Ko MS; Bandyopadhyay G; Das S; Roth DM; Sahoo D; Webster NJG; Sheikh F; Ghosh G; Patel HH; Ghosh P; van den Bogaart G; Mahata SK
Hypertension; 2021 May; 77(5):1670-1682. PubMed ID: 33826401
[TBL] [Abstract][Full Text] [Related]
14. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel loci affecting circulating chromogranins and related peptides.
Benyamin B; Maihofer AX; Schork AJ; Hamilton BA; Rao F; Schmid-Schönbein GW; Zhang K; Mahata M; Stridsberg M; Schork NJ; Biswas N; Hook VY; Wei Z; Montgomery GW; Martin NG; Nievergelt CM; Whitfield JB; O'Connor DT
Hum Mol Genet; 2017 Jan; 26(1):233-242. PubMed ID: 28011710
[TBL] [Abstract][Full Text] [Related]
16. Catestatin and vasostatin concentrations in healthy dogs.
Srithunyarat T; Hagman R; Höglund OV; Olsson U; Stridsberg M; Jitpean S; Lagerstedt AS; Pettersson A
Acta Vet Scand; 2017 Jan; 59(1):1. PubMed ID: 28049540
[TBL] [Abstract][Full Text] [Related]
17. Plasma Catestatin in Patients with Acute Coronary Syndrome.
Xu W; Yu H; Wu H; Li S; Chen B; Gao W
Cardiology; 2017; 136(3):164-169. PubMed ID: 27681934
[TBL] [Abstract][Full Text] [Related]
18. Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction.
Zhu D; Xie H; Wang X; Liang Y; Yu H; Gao W
PLoS One; 2015; 10(4):e0122993. PubMed ID: 25848973
[TBL] [Abstract][Full Text] [Related]
19. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
Uusimaa P; Tokola H; Ylitalo A; Vuolteenaho O; Ruskoaho H; Risteli J; Linnaluoto M; Peuhkurinen K;
Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).
Jitpean S; Stridsberg M; Pettersson A; Höglund OV; Holst BS; Hagman R
BMC Vet Res; 2015 Jan; 11():14. PubMed ID: 25636335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
